Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.60 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.60 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.43 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.43 |
| ▸ | PRKCG | P05129 | 1/20 | 0.43 |
| ▸ | PRKCB | P05771 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | PRKCH | P24723 | 1/20 | 0.43 |
| ▸ | PRKCI | P41743 | 1/20 | 0.43 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.43 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | TLR4 | O00206 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8734449 | 0.92 | CDK1 (0.60) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL5705134 | 0.90 | CDK1 (0.58) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL28151557 | 0.89 | CDK1 (0.59) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL9329580 | 0.89 | CDK1 (0.61) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL7555980 | 0.88 | CDK1 (0.62) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL18027489 | 0.88 | CDK1 (0.62) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL28359902 | 0.86 | CDK1 (0.64) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL9298841 | 0.86 | CDK1 (0.64) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL1879409 | 0.86 | CDK1 (0.66) | CDK1CCNB1LDHAEPHX2PRKD3 | |
| SCHEMBL27633793 | 0.86 | CDK1 (0.58) | CDK1CCNB1LDHAEPHX2PRKD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7737146-B2 | Compound, useful for pancreatic lipase inhibition and the process for isolation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2010-06-15 | — | — | US | disclosed |
| US-20090163443-A1 | NOVEL COMPOUND, USEFUL FOR PANCREATIC LIPASE INHIBITION AND THE PROCESS FOR ISOLATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163443-A1 | NOVEL COMPOUND, USEFUL FOR PANCREATIC LIPASE INHIBITION AND THE PROCESS FOR ISOLATION THEREOF | PNLIP, LPL, LIPA | CDK1 2379/4885CCNB1 1671/4885LDHA 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.